Evidence map›Paper›PMID 40968170›Full record

ArticleNature communications2025

Author Correction: Targeting ferroptosis protects against experimental (multi)organ dysfunction and death.

Samya Van Coillie, Emily Van San, Ines Goetschalckx, Bartosz Wiernicki, Banibrata Mukhopadhyay, Wulf Tonnus, Sze Men Choi, Ria Roelandt, Catalina Dumitrascu, Ludwig Lamberts and 19 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Samya Van CoillieVIB-UGent Center for Inflammation Research, Ghent, Belgium.
Emily Van SanVIB-UGent Center for Inflammation Research, Ghent, Belgium.
Ines GoetschalckxDepartment of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Bartosz WiernickiVIB-UGent Center for Inflammation Research, Ghent, Belgium.ORCID http://orcid.org/0000-0003-2694-8986
Banibrata MukhopadhyayDepartment of Nephrology, Muljibhai Patel Society for Research in Nephro-Urology, Nadiad, India.
Wulf TonnusDepartment of Internal Medicine 3, University Hospital Carl Gustav Carus, the Technische Universität Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0002-9728-1413
Sze Men ChoiVIB-UGent Center for Inflammation Research, Ghent, Belgium.
Ria RoelandtVIB-UGent Center for Inflammation Research, Ghent, Belgium.
Catalina DumitrascuDepartment of Pharmaceutical Sciences, Toxicological Centre, University of Antwerp, Antwerp, Belgium.
Ludwig LambertsDepartment of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Geert DamsDepartment of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Wannes WeytsVIB-UGent Center for Medical Biotechnology, Ghent, Belgium.
Jelle HuysentruytVIB-UGent Center for Inflammation Research, Ghent, Belgium.
Behrouz HassanniaVIB-UGent Center for Inflammation Research, Ghent, Belgium.
Irina IngoldInstitute of Metabolism and Cell Death, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany.
Suhas LeleDepartment of Nephrology, Muljibhai Patel Society for Research in Nephro-Urology, Nadiad, India.
Evelyne MeyerDepartment of Pharmacology, Toxicology and Biochemistry, Ghent University, Merelbeke, Belgium.
Maya BergDepartment of Pharmaceutical Sciences, Toxicological Centre, University of Antwerp, Antwerp, Belgium.
Ruth SeurinckVIB-UGent Center for Inflammation Research, Ghent, Belgium.ORCID http://orcid.org/0000-0002-6636-7572
Yvan SaeysVIB-UGent Center for Inflammation Research, Ghent, Belgium.
An VermeulenDepartment of Bioanalysis, Ghent University, Ghent, Belgium.
Alexander L N van NuijsDepartment of Pharmaceutical Sciences, Toxicological Centre, University of Antwerp, Antwerp, Belgium.
Marcus ConradInstitute of Metabolism and Cell Death, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany.ORCID http://orcid.org/0000-0003-1140-5612
Andreas LinkermannDepartment of Internal Medicine 3, University Hospital Carl Gustav Carus, the Technische Universität Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0001-6287-9725
Mohan RajapurkarDepartment of Nephrology, Muljibhai Patel Society for Research in Nephro-Urology, Nadiad, India.
Peter VandenabeeleVIB-UGent Center for Inflammation Research, Ghent, Belgium.ORCID http://orcid.org/0000-0002-6669-8822
Eric HosteIntensive Care Unit, Ghent University Hospital; Ghent University, Ghent, Belgium.
Koen AugustynsDepartment of Pharmaceutical Sciences, Toxicological Centre, University of Antwerp, Antwerp, Belgium.ORCID http://orcid.org/0000-0002-5203-4339
Tom Vanden BergheVIB-UGent Center for Inflammation Research, Ghent, Belgium. Tom.VandenBerghe@uantwerp.be.ORCID http://orcid.org/0000-0002-1633-0974

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40968170
PMCPMC12446483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.